Remove FDA Remove Pharma Remove Pharmaceutical manufacturing Remove Physicians
article thumbnail

US legislative update: takeaways for European pharma

European Pharmaceutical Review

For example, the US recently passed the Inflation Reduction Act, 1 which requires the Secretary of Health and Human Services (HHS) to negotiate prices for certain physician-administered and retail prescription drugs covered under Medicare Parts B and D. 3) policing anticompetitive settlements between competing drug manufacturers.

article thumbnail

How one pharma “family business” places patients first

pharmaphorum

When people think about pharma, they often think about “big” pharma: large, faceless corporations. The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We But rare diseases are a particularly important and challenging focus area.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

10 New Solutions, Strategies, and Devices to Boost Adherence

PM360

Levrx also engages physician groups and members directly, giving healthcare consumers the information needed at the point of care to keep costs low, avoid prescription rewrites, and prevent cost-related non-adherence. andrew.mills@caretrack.com CareTrack Health is a fully integrated physician practice extension. CareTrack Health.

article thumbnail

Ep. 002 – John Mack Podcast Transcript

Pharma Marketing Network

RJ Lewis (EHS): Hello, this is RJ Lewis and we’re back for Episode 2 with John Mack and Don Langsdorf, and we’re talking about the rebirth of Pharma Marketing and Pharma Guy. So, you continue with Pharma Marketing news. Where do you see it going? RJ Lewis (EHS): So, thanks for that question. That’s our vision.

Pharma 52